Does CRISABOROLE Cause Product use in unapproved indication? 242 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 242 reports of Product use in unapproved indication have been filed in association with CRISABOROLE (Eucrisa). This represents 3.1% of all adverse event reports for CRISABOROLE.
242
Reports of Product use in unapproved indication with CRISABOROLE
3.1%
of all CRISABOROLE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product use in unapproved indication From CRISABOROLE?
Of the 242 reports, 1 (0.4%) required hospitalization.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRISABOROLE. However, 242 reports have been filed with the FAERS database.
What Other Side Effects Does CRISABOROLE Cause?
Drug ineffective (1,815)
Application site pain (1,414)
Burning sensation (975)
Off label use (673)
Condition aggravated (613)
Pain (468)
Pruritus (378)
Rash (342)
Eczema (308)
Erythema (285)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which CRISABOROLE Alternatives Have Lower Product use in unapproved indication Risk?
CRISABOROLE vs CRIZANLIZUMAB
CRISABOROLE vs CRIZANLIZUMAB-TMCA
CRISABOROLE vs CRIZOTINIB
CRISABOROLE vs CROFELEMER
CRISABOROLE vs CROMOLYN